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This report summarizes angigraphic and long-term clioical outcome in 75 consecutive patients who underwent coronary angoplasty of ore or more saphenoua vein graft lesions fir medically refractory ischemlc syndromes. This series includes patients with both anatomic and physiologic extremes who arm at Increased risk for repeat bypass surpry . Shunt-term clinical coronary angioplasty results in these patients were contrasted with proected and observed outcomes from the Veterans Affairs Surgical Registry of the coronary artery bypass graft alternative . Long-term clinical follow-up was provided. This report supports the concept that coronary angioplasty of saphenous vein graft lesions is IACC Vat. 23, Na. 5 April 1990 : 1066 an alternative to reoperation in patients with medically refractory unstable angina and previous coronary artery bypass graft tmgery.
Methods
Patient group . Between December 1986 and March 1993 . 'S patients with unstable angina and at least one previous ,oronary artery bypass graft operation underwent sapheous vein graft bailooa angioplasty . All patients had severe tsehemic syndromes (Canadian angina classes III and IV despite medical therapy. Thirty-six patients had reversible electrocardiographic changes of ischemia recorded at rest .
Mglepiassy protects. Coronary angioplasty was performed by standard technique (3) . All patients were treated with aspirin (325 mg every day) and intravenous hepatic or nitroglycerin, or both . Seventy patients (93%) consented to salvage coronary angioplasty, which specified that no surgical standby was available because of the surgeons perceptiao of "prohibitive" risk (3). insraaortic balloon augasentalion was instituted because of hemodytamic instability in nine patients. Anatomic assessment of lesion severity was determined by visual inspection in two or more angiographic views . Intravenous heparin (10,000-U bolus with periodic additional boluses) was given to a8 patients. Adjunctive plsemacotherapy Included 1) in racoronary nitroglycerin (>208 pg) in every patient; 2) inuasapheasras vein graft heparin (5,008 to 20,008 U) in 72 of 75 patients : 3) ineasapbenous vein graft orokinnse (250,000 1a I million U) in 16 of 75 patients; and 4) law dose wat8rin (2 to 5 mg) throughout the hospital stay in 74 of 75 patients .
Ddbd §onw. Aagiarapk k sure-ear was defined as a residtd l men narrowing 550% . Compiicatioas were defined as major if death, myocardial in%rcelon or emergent coronary artery bypass grafting occurred during index hospitalization . Cgnied aucren was achieved if stabilization of patient's c9la'tcalsta ustccurred . with eventual hospital discharge and no major complications during the index hospitalization . Late cardsc evenrr were defined as death, myocardial mihretlon or repeat revascularizstion (coronary artery bypass graft sugary or coronary angioplasty) .
Fo6owrgi . All patients were followed up by return clinic visits, telephone concoct or chart review for clinical symptoms, need for repeat revascularization or death. Because patients were all eligible veterans from Denver's catchment area, atheteriation. angioplasty and surgical records c(ar hospital were screened to Identify subsequent procedures in those patients Surglral rkk went . Coronary artery bypass graft surgery survived database been collected by the Department d Veterans Af<ans Cardiac Risk Assessment Program since April 1987 in a program to assess preoperative surgical risk (7). These data have resulted in a logistic regression predic tine model based on 11 risk variables (previous heart surgery, cardiomegdy, age, serum creatinine, presence of pa dphrtrl vascular disease, presence of chronic obstructive MORRISON ET AL . 1067 VEIN ORAFr ANnenpLAATV pulmonary disease, recent myocardial infarction, New York Heart Association functional class, current diuretic use, intravenous nitroglycerin ttae, preoperative baboon pump use) that estimate expected surgical mortality . These variables have been used to predict the expected surgical risk for the patients with saphenoss vein graft coronary angioplasty in this report had they undergone coronary artery bypass graft surgery. This value can be compared with that for observed angioplasty mortality .
Coronary artery bypass graft surgery central group . Patients with unstable angina who underwent bypass surgery were extracted from the Veterans Affairs Cardiac Risk Assessment Program Registry on the basis of the presence of at least one of the following six high surgical risk factors. previous corosmy artery bypass graft surgery, age >70 years. myocardial infarction within 30 days, left ventricular ejection fraction <035, intravenous nitroglycerin required, istraaortic balloon pump required . A total of 2,370 patients were found who underwent coronary artery bypass surgery between April 1. 1987 and December 31, 1988. Survival data for these patients were obtained from a second dam file (Beneficiary Idemificalion Records Locator Subsystem) by matching social security numbers . Experience suggests that most deaths would appear in this data set but that some deaths due to coronary artery bypass surgery would be missed .
Statistical considerations. Observed angioplasty shortterm mortality was compared with predicted coronary artery bypass surgery mortality, and obi-square analysis was used to test for differences at the 5% level of significance . Follow-up 5-year survival was evaluated by the KapltmMeier product limit estimates for years I to 5 after index treatment . This was done for the 75 patients with sapheoous vein VA coronary angioplasty and for the coronary artery bypass graft surgery control getup extracted from the Veterans Affairs Cardiac Risk Assessment Program Registry .
Maadmul likelihood estimates of yearly survival and standard errors were obtained for censured data to compare survival in the saphenoua vein graft coronary angioplnsty, and coronary artery bypass graft surgery control groups. Differences in survival were tested by a Student r test using 5% statistical significance. curve S(b) = exp(-b x t) where t = years after surgery. This corresponds to a yearly survival rate (95% confidence interval) or SIPPA) = exp( -caw) = 94% (91% to 97%1:
Results
S(CABG) = exp( -0A32) =97% (962 to 97%) .
Discussion
In this highly selected group of patients with coronary artery bypass gmf surgery and medically, refractory unstable angina, angioplasty and adjunctive intracosonary phar n acothempy of odd saphenous vein grafts was a reasonable alternative to reoperatias. Patients with coronary artery bypass gait surgery who present with unstable ischemic syndromes frequently arc older, have had a previous or recent myocardial infarction and . often . significant conorbidhy that places these patients al high risk for reoperation. In the Veterans Alb ins system, where results of a8 coronary salary bypass operations performed in 45 centers me mom toned, seuperatiar is associated with -9% mortality (7). This operative mortality is higher Chum in ants-Veterans Affairs facilities but reflects the [nee risk for the veteran population . In our study, the ergirceed 30-day corimry artery bypass mortality rate was predicted at 19% for these 75 patients had they unilesli a reeperalion in our hospital . Although our MW 3042Y metality rate for angioplasty was 3% and compares quite favorably to that predicted for repeat surgery (18%), the long-term mortality rate for angioplasty was rig cool at 27% for a 5-mouth to 3-year follow-up period . However, our study group in general had a relatively guarded long-term prognosis gives the fact that 31% had a left ejectim fractiaa 50.35, and 67% had maim comorbidity (Table 1) .
In 0 effort to provide a more comparable control than MORMON Er AL. 1069 Yk114 GBAFr ANYIOPLASTY projections . we surveyed the Veterans Affairs Surgical Re , istry for patients meeting our criteria of medically refractory rest angina and high surgical risk. The high surgical risk group includes either age >70 years or left ventricular ejection fraction <0 .35 or intravenous nitroglycerin therapy at time of surgery or inttaaoetic balloon pump at time of surgery or recent (30 days) myocardial infntction or p=-coronary bypass graft surgery . This defines the 2,370 veterans who wee followed up by means of the Beneficiary Identification Records Locator System and from which we derived the observed coronary artery bypass graft surgery deaths shown in Table 0 . Because every analysis of Veterans Affairs Surgical Registry data has shown that post.corotmry bypass is the highest of these six high risk factors, the angoplasty group is unequivocally at higher risk than the bypass surgery group (all patients in the angoplasty group had bypass surgery). Our date suggest that the short-term survival rate was better after angioplasty, but over a longer time there was no difference .
Reservations Concerning tog eptasq hr patients after car onary artery bypass graft surgery . Angioplasty of old vein grafts can be complicated by thrombosis . embolization and dissection and has been associated with higher rates of abrupt occlusion and late resteaosis (8-17). Previous reports have recommended alternative treatment strategies in such patients (8, 17) . The patients studied in this report were also at risk for abrupt occlusion and complications because all patients had refractory, unstable angina (21-24) . Restenosis rates were also higher in this subgroup. Furthermore, a recent review of the published world data recommends outran I) with regard to angioplasty of totally occluded veins ; 2) in angioplasty of vein graft lesions that are likely to lead to shock with sectusioo; and 3) with grafts z4 years old ifrepeat bypass surgery is a viable option (8) . We agree with that position. but our data support extending the application of angioplasty in selected patients with these characteristics, especially in patients who are at increased risk for reeperation .
Role d asnod(ve Yraroroaary pbwmamlhaapy. All patients in this study received adjunctive intraconomay therapy consisting of heparin, urokinase and nitroglycerin . To time there are no dam that indicate that intracoronary heparin prevents score occlusions or restenosis in vein grafts. We routinely and safely administered intracoronary heparin in all patients aficr angioplasty an theoretic grounds, but we have no objective data to support its use . Intracoronary wokinase has been effective in recannalization of occluded or diffusely diseased vein grafts (19, 20) . Residual thrombus after angioplasty may also predispose patients to suhacutc occlusion and reateaosis (34). We routinely administered intracoronary urokinaae for vein lesions that appeared irregular or hazy or contained obvious filling defects. Our reported angiographic and clinical success rates in these high risk patients for short-term complications may reflect in part the liberal use of adjunctive intracoronary pharmacotherapy . 
